{
    "2019-06-03": [
        [
            {
                "time": "2023-05-30",
                "original_text": "Novartis (NVS) Announces Various Data Presentations at ASCO",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Data Presentations",
                        "ASCO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-05-30",
                "original_text": "Roche Presents Positive Data on Xolair & Updates From ASCO",
                "features": {
                    "keywords": [
                        "Roche",
                        "Positive Data",
                        "Xolair",
                        "ASCO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-05-30",
                "original_text": "Gilead Presents Data on CAR T Cell Therapy Candidate at ASCO",
                "features": {
                    "keywords": [
                        "Gilead",
                        "CAR T Cell Therapy",
                        "ASCO"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-05-30",
                "original_text": "Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Lung Cancer",
                        "Capmatinib",
                        "Canakinumab",
                        "Clinical Trials"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}